This is a working overview of pituitary axis, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-12-19 and is reviewed periodically as new material appears.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The post–Cold War era was marked by sustained economic prosperity in much of the Western world, particularly in the United States, alongside a broad wave of democratization across Latin America, Africa, and Central, South-East, and Eastern Europe. Sociologist Immanuel Wallerstein expresses a less triumphalist view, arguing that the end of the Cold War is a prelude to the breakdown of Pax Americana. In his Foreign Policy essay entitled, "The Eagle Has Crash Landed", Wallerstein argues, "The collapse of communism in effect signified the collapse of liberalism, removing the only ideological justification behind US hegemony, a justification tacitly supported by liberalism's ostensible ideological opponent".
Vegetable soup is a common soup prepared using vegetables (including leaf vegetables, and sometimes loosely mushrooms) as primary ingredients. It dates to ancient history, and in modern times is also a mass-produced food product.
== External links == United States Congress. "Wilmer Mizell (id: M000833)". Biographical Directory of the United States Congress. Career statistics from MLB · Baseball Reference · Baseball Reference (Minors) · Retrosheet · Baseball Almanac Mizell's Infoplease Bio
spacer Also intergenic spacer (IGS) or non-transcribed spacer (NTS). Any sequence or region of non-coding DNA separating neighboring genes, whether transcribed or not. The term is used in particular to refer to the non-coding regions between the many repeated copies of the ribosomal RNA genes. See also intergenic region.
Sources: en.wikipedia.org
=== 25 June === The International Criminal Court issued arrest warrants against former Russian defence minister Sergei Shoigu and Chief of the General Staff Valery Gerasimov for war crimes and crimes against humanity pertaining to strikes on Ukrainian energy facilities from 2022 to 2023. The HUR claimed to have blown up a Russian ammunition depot in Voronezh Oblast. The governor of Belgorod Oblast claimed that one person was killed in a drone strike. Czech Prime Minister Petr Fiala said that the first batch of artillery ammunition purchased under the Czech-led initiative had been delivered to Ukraine. Russia and Ukraine conducted a prisoner exchange involving 90 POWs from each side. One of the prisoners swapped was a Ukrainian Orthodox priest who had been convicted and sentenced for “justifying Russian armed aggression“.
n C4H4NH + 2 FeCl3 → (C4H2NH)n + 2 FeCl2 + 2 HCl Upon further oxidation, these polymers become conductive, forming p-doped conducting polymers. These typically owe their conductivity to the transport of (positive) polarons, radical cation defects with resonance structures where the radical and cation are on separate atoms, associated with a localized change in bond-length alternation within the conjugated system, as well as bipolarons, classically considered to be non-radical dications in equilibrium with polarons.
Historian Niall Ferguson said: "Cold War II is different, because in Cold War II, China's the senior partner, and Russia's the junior partner", and "in Cold War II, the first hot war breaks out in Europe, rather than Asia". Another difference in the Second Cold War is the higher economic "interdependence and centrality of network-based competition, particularly in infrastructure, finance, production, and digital networks", as stated in a September 2023 journal article of Geopolitics.
Darbar ( transl. Court) is a 2020 Indian Tamil-language action thriller film written and directed by AR Murugadoss, and produced by Allirajah Subaskaran under the banner Lyca Productions. The film stars Rajinikanth, Suniel Shetty, Nayanthara and Nivetha Thomas. It follows Aaditya Arunasalam (Rajinikanth), the commissioner of Mumbai Police, who sets out to curb the city's rampant drug-trafficking and prostitution. When he uncovers a deep controversy linked to an international drug lord, however, he tries to fulfill his secret agenda. The film is Rajinikanth's first role as a police officer in 27 years following Pandiyan (1992). The project's working title was Thalaivar 167 and the title Darbar was officially announced on 9 April 2019. Principal photography commenced the same month, mostly in Mumbai, and was completed in October 2019. Anirudh Ravichander composed the music for the film. The cinematographer was Santosh Sivan and the editor was A. Sreekar Prasad. Darbar was released theatrically in India on 9 January 2020, coinciding with the Pongal festival. The film met with mixed reviews upon release with praise for Rajinikanth’s performance and grossed ₹250 crore at the box office, making it the highest-grossing Tamil film of 2020 and 4th highest-grossing Indian film of 2020. Darbar became Rajinikanth’s fifth film to gross over ₹200 crore worldwide, following Enthiran, Kabali, 2.0, and Petta.
=== Immediate-spin cross-matching === Immediate-spin cross-matching (ISCM) is an abbreviated form of cross-matching that is faster, but less sensitive; its primary use is to detect a mismatch between ABO blood types. It is an immediate test that involves combining the patient's serum and donor's red blood cells at room temperature, then centrifuging the sample and observing for agglutination or hemolysis. A lack of agglutination or hemolysis indicates a negative test reaction, or compatible match. ISCM is not appropriate in all circumstances; if the recipient's antibody screen is positive, or if they have had a positive antibody screen in the past, a full crossmatch is performed instead.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
It shares the 44-residue sequence of human GHRH but carries an added trans-3-hexenoyl group at its N-terminus. That addition does not occur in the natural hormone and serves mainly to resist enzymatic breakdown. The receptor target and signaling pathway remain the same.